ADHOC Mindfulness-Based Research - An Intervention to Address Loneliness Among Older People Living With HIV
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 202
- 试验地点
- 2
- 主要终点
- Loneliness
研究概览
简要总结
The AMBR Study (ADHOC Mindfulness-Based Research Study) is a randomized controlled trial that examines the effectiveness of teaching mindfulness-based techniques through online lessons to combat loneliness, anxiety, and depression among people living with HIV over the age of 50. It is a substudy of the ADHOC study (ClinicalTrials.gov identifier NCT04311554).
详细描述
The AMBR Study is a randomized controlled trial that examines the effectiveness of teaching mindfulness-based techniques through online lessons to combat loneliness, anxiety, and depression among people living with HIV who are over the age of 50 and enrolled in ADHOC (ClinicalTrials.gov identifier NCT04311554). The intervention consists of 14 mindfulness audio lessons, each approximately 20-minutes long. The mindfulness lessons are designed to develop three core skills: concentration (the ability to maintain focus on present-moment experiences), clarity (the ability to pinpoint exactly what you are experiencing in each moment), and equanimity (openness to experience).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •ADHOC participant with a score of 4 or higher on the 3-item Loneliness Questionnaire from their ADHOC profile
- •Clinical diagnosis of HIV
- •Able to read and write in English
- •Able and willing to provide online informed consent and complete study activities online
- •Access to a smartphone or computer
排除标准
- •Acute medical problem(s) requiring immediate inpatient treatment
结局指标
主要结局
Loneliness
时间窗: Baseline and follow-up, 25 days
Change in loneliness using the 3-Item Loneliness Questionnaire (3IL). 3IL scores range from 3-9, with higher scores indicating greater loneliness.
次要结局
- Anxiety(Baseline and follow-up, 25 days)
- Depression(Baseline and follow-up, 25 days)